World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00283374
Date of registration: 25/01/2006
Prospective Registration: No
Primary sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Public title: Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome
Scientific title: A Prospective, Longitudinal Multicenter, Nontreatment, Exploratory Biomarker Study of Metabolic Syndrome in Subjects Undergoing Laparoscopic Roux-En-Y Gastric Bypass Bariatric Syndrome
Date of first enrolment: October 2005
Target sample size: 120
Recruitment status: Terminated
URL:  http://clinicaltrials.gov/show/NCT00283374
Study type:  Observational
Study design:  Observational Model: Defined Population, Time Perspective: Longitudinal  
Phase:  N/A
Countries of recruitment
Italy Sweden United States
Contacts
Name:     Medical Monitor
Address: 
Telephone:
Email:
Affiliation:  Wyeth is now a wholly owned subsidiary of Pfizer
Name:     Trial Manager
Address: 
Telephone:
Email:
Affiliation:  For Italy, decresg@wyeth.com
Name:     Trial Manager
Address: 
Telephone:
Email:
Affiliation:  For Sweden, MedInfoNord@wyeth.com
Key inclusion & exclusion criteria

Inclusion Criteria:

- All subjects must be approved by both insurance and site standard of care to undergo
the Roux-en-Y gastric bypass procedure

- Male and Female Candidates for Roux-en-Y Bariatric Surgery

- Must be diagnosed with Metabolic Syndrome; having abdominal obesity and at least 2
other features of the syndrome per IDF (International Diabetes Foundation)

- Obese control group:Subjects should be obese and should not have any other features
of metabolic syndrome.

Exclusion Criteria:

- Any subjects with prior bariatric surgery

- No other major surgery within the last 6 months

- Diabetes on treatment with hypoglycemic medication in the previous 6 months

Other exclusions apply



Age minimum: 18 Years
Age maximum: 55 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Morbid Obesity
Metabolic Disease
Intervention(s)
Procedure: Laparoscopic Roux-en-Y Gastric Bypass
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
9804Z1-900
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history